EichorEICHOR
Location: Middletown Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Middletown

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive
Phase 2 · Memorial Sloan Kettering Monmouth (Limited Protocol Activiti · Memorial Sloan Kettering Cancer Center · NCT07359859Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors
Phase 2 · Memorial Sloan Kettering Monmouth (All Protocol Activities) · Memorial Sloan Kettering Cancer Center · NCT06728579This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · MSK Monmouth · Pfizer · NCT07028853A Registry for People With T-cell Lymphoma
Phase N/A · Memorial Sloan Kettering Monmouth (All protocol activities) · Memorial Sloan Kettering Cancer Center · NCT05978141MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Memorial Sloan Kettering Monmouth · National Cancer Institute (NCI) · NCT05564390Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Memorial Sloan Kettering Monmouth · NRG Oncology · NCT05624996A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Phase 1 · MSK Monmouth · Pfizer · NCT07206225A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Appr
Phase 2 · Memorial Sloan Kettering Monmouth (Limited Protocol Activiti · Memorial Sloan Kettering Cancer Center · NCT05534438A Study of Tucatinib and Trastuzumab in People With Rectal Cancer
Phase 2 · Memorial Sloan Kettering Monmouth (Limited Protocol Activiti · Memorial Sloan Kettering Cancer Center · NCT05672524A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
Phase 1 · Memorial Sloan Kettering Monmouth (Limited protocol activiti · Memorial Sloan Kettering Cancer Center · NCT06623396Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · Alliance for Clinical Trials in Oncology · NCT07321652A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
Phase 2 · Memorial Sloan Kettering Monmouth (All Protocol Activities) · Memorial Sloan Kettering Cancer Center · NCT06594991A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
Phase 1 · Memorial Sloan Kettering Monmouth (Limited Protocol Activiti · Memorial Sloan Kettering Cancer Center · NCT06807632A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
Phase 2 · Memorial Sloan Kettering Monmouth (Limited protocol activiti · City of Hope Medical Center · NCT05751434A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
Phase 1 · Memorial Sloan Kettering Monmouth (Limited protocol activiti · Memorial Sloan Kettering Cancer Center · NCT07011004Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: RO
Phase 2 · Memorial Sloan Kettering Monmouth · Memorial Sloan Kettering Cancer Center · NCT01639508A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacyti
Phase 2 · Memoral Sloan Kettering Monmouth · Memorial Sloan Kettering Cancer Center · NCT07231952A Study Collecting Health Information to Understand and Prevent Gastric Cancer
Phase N/A · Memorial Sloan Kettering Monmouth (All Protocol Activities) · Memorial Sloan Kettering Cancer Center · NCT06370143An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Inte
NA · Memorial Sloan Kettering Monmouth (Limited Protocol Activiti · Memorial Sloan Kettering Cancer Center · NCT05420064A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
Phase 2 · Memorial Sloan Kettering Monmouth (All Protocol Activities) · Memorial Sloan Kettering Cancer Center · NCT06773208Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Phase N/A · PrECOG, LLC. · NCT06538038A Study of Lung Cancer Screening in People With Unexplained Weight Loss
Phase N/A · Memorial Sloan Kettering Monmouth (All Protocol Activities) · Memorial Sloan Kettering Cancer Center · NCT06717334A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Memorial Sloan Kettering - Monmouth ( Site 4057) · Merck Sharp & Dohme LLC · NCT06077760Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · SWOG Cancer Research Network · NCT06769126A Study of Meaning-Centered Psychotherapy for Caregivers to People With Cancer
NA · Memorial Sloan Kettering Monmouth (Limited protocol activiti · Icahn School of Medicine at Mount Sinai · NCT06307535A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer
Phase 1 · Memorial Sloan Kettering Monmouth (Consent Only) · Memorial Sloan Kettering Cancer Center · NCT06863233A Study of Pembrolizumab and Cryoablation in People With Breast Cancer
Phase 1 · Memorial Sloan Kettering Monmouth (Limited protocol activiti · Memorial Sloan Kettering Cancer Center · NCT06246968A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
Phase 2 · Memorial Sloan Kettering Monmouth (Limited Protocol Activiti · Memorial Sloan Kettering Cancer Center · NCT07483307Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Garnet Health Medical Center · NRG Oncology · NCT05174169Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
Phase 2 · Memorial Sloan Kettering Monmouth (Limited Protocol Activiti · Memorial Sloan Kettering Cancer Center · NCT04410796
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.